Chair of the Department of Microbiology and Molecular Genetics[1]
Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019.
she has developed and used non-human primate models for TB research for 25 years
Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments. · immunology, host-pathogen interactions, vaccines, and drugs
Reviewed sources document Education record: Bachelor of Science in Biochemistry, Education record: Bachelor of Science in Biochemistry, from the University of California at Davis, Education record: PhD in Microbiology and Immunology, and Education record: PhD in Microbiology and Immunology from University of California at Berkeley.
Explore education and trainingReviewed sources document Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments. and immunology, host-pathogen interactions, vaccines, and drugs. Explore attributed publications and research affiliations.
Explore researchChair of the Department of Microbiology and Molecular Genetics[1]
Distinguished Fellow of AAI[1]
Distinguished Professor[1]
Fellow of the American Academy of Microbiologists[1]
Health Sciences Endowed Chair of Microbiology[1]
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.[1]
Bachelor of Science in Biochemistry[1]
Bachelor of Science in Biochemistry, from the University of California at Davis[1]
PhD in Microbiology and Immunology[1]
PhD in Microbiology and Immunology from University of California at Berkeley[1]
Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.[1]
immunology, host-pathogen interactions, vaccines, and drugs[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
17 source claims · Reviewed Sep 9, 2026
Biographical context: Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019.
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Biographical context: she has developed and used non-human primate models for TB research for 25 years
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Degree: Bachelor of Science
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Degree: PhD
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Education record: Bachelor of Science in Biochemistry
She has a Bachelor of Science in Biochemistry, from the University of California at Davis
Education record: Bachelor of Science in Biochemistry, from the University of California at Davis
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Education record: PhD in Microbiology and Immunology
and a PhD in Microbiology and Immunology from University of California at Berkeley.
Education record: PhD in Microbiology and Immunology from University of California at Berkeley
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Identity: JoAnne Flynn
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Professional role: Chair of the Department of Microbiology and Molecular Genetics
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Professional role: Distinguished Fellow of AAI
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Professional role: Distinguished Professor
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Professional role: Fellow of the American Academy of Microbiologists
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Professional role: Health Sciences Endowed Chair of Microbiology
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Professional role: JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Research interests: Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
JoAnne Flynn is a Distinguished Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine and the Health Sciences Endowed Chair of Microbiology. She has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD in Microbiology and Immunology from University of California at Berkeley. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. She served as a Councilor for the American Association of Immunologists (AAI) and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of AAI. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Chancellor’s Distinguished Research Award in 2019. She served on the Board of Scientific Counselors for the NIH NIAID and was previously a Section Editor at PLoS Pathogens and an Editor at Infection and Immunity and The Journal of Immunology. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for 25 years. Dr. Flynn’s research uses cutting-edge tools and technologies, including PET CT imaging, to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Research interests: immunology, host-pathogen interactions, vaccines, and drugs
Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs